← Eichor
Study identifier: NCT06308055 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Abiomed Impella RT-DAQ - Observational Study

Condition: Cardiogenic Shock  ·  Sponsor: Abiomed Inc.

PhaseN/A
Planned participants125
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Abiomed IMPELLA-RT-DAQ - Impella Real Time Data AcQuisition

This description comes directly from the study's public registry record.

Talk to the study team

Andreas Goetzenich, MD, PhD, MBA, FAHA, FESC  ·  +49 241 8860  ·  AGoetze1@ITS.JNJ.com

Kirstin Starke  ·  +49 241 8860  ·  KStarke@ITS.JNJ.com

Always discuss trial participation with your own doctor first.

Locations (4)

Uniklinik RWTH AachenAachen, North Rhine-Westphalia, GermanyActive Not Recruiting
UKSH Campus KielKiel, Schleswig-Holstein, GermanyNot Yet Recruiting
IRCCS Ospedale San RaffaeleMilan, MI, ItalyNot Yet Recruiting
Universitätsspital BaselBasel, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06308055